Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

12 week prospective double blind placebo controlled randomized trial of Seroquel SR for alcohol dependence and comorbid anxiety

Trial Profile

12 week prospective double blind placebo controlled randomized trial of Seroquel SR for alcohol dependence and comorbid anxiety

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Nov 2008

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Alcoholism; Anxiety disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 30 Nov 2008 Status changed from recruiting to completed.
    • 08 Apr 2008 The expected completion date for this trial is now 1 Jul 2008, as reported by clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top